Triple

T4220721
Position Surface form Disambiguated ID Type / Status
Subject Division of Clinical Innovation E94332 entity
Predicate partOf P40 FINISHED
Object National Center for Advancing Translational Sciences E16877 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: National Center for Advancing Translational Sciences | Statement: [Division of Clinical Innovation, partOf, National Center for Advancing Translational Sciences]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: National Center for Advancing Translational Sciences
Context triple: [Division of Clinical Innovation, partOf, National Center for Advancing Translational Sciences]
  • A. National Center for Advancing Translational Sciences chosen
    The National Center for Advancing Translational Sciences is a U.S. biomedical research center focused on accelerating the development and delivery of new diagnostics, treatments, and cures by improving the translational science process.
  • B. National Institute of General Medical Sciences
    The National Institute of General Medical Sciences is a U.S. government biomedical research institute that supports fundamental, non-disease-specific science and training to advance understanding of biological processes and lay the groundwork for medical advances.
  • C. Office of Translational Sciences
    The Office of Translational Sciences is a scientific office within the U.S. Food and Drug Administration that advances the translation of biomedical research into safe and effective drug therapies through regulatory science, research, and policy development.
  • D. National Institutes of Health
    The National Institutes of Health is the United States’ primary federal biomedical research agency, supporting and conducting medical research to improve public health.
  • E. Center for Scientific Review
    The Center for Scientific Review is the National Institutes of Health component responsible for overseeing the peer review of most grant applications to ensure scientific merit and integrity in funding decisions.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69b3451997e08190851db4a9a588837d completed March 12, 2026, 10:58 p.m.
NER Named-entity recognition batch_69b34e0c84548190b051d32d434cbf04 completed March 12, 2026, 11:36 p.m.
NED1 Entity disambiguation (via context triple) batch_69b6509a86a081908435094d0e80e9f4 completed March 15, 2026, 6:24 a.m.
Created at: March 12, 2026, 11:04 p.m.